An oral immunotherapy drug, tested in a 10-nation trial, could be the first FDA-approved medication for people living with peanut allergies. The medicine, AR101, is derived from peanut protein and could help patients build tolerance for peanuts. “The results of this landmark trial are likely to lead to the first FDA-approved treatment for food allergy… Continue reading Allergic to Peanuts? Relief May Be at Hand